United States · Federal contract register · Supplier record

UROGEN PHARMA INC

Line: Drugs and biologicals (6505)Register loaded to November 2025Compiled 17 October 2026

UROGEN PHARMA INC — United States · Federal contract register · Supplier record: 8 contracts, all years ($811,169 · Jun 2023 – Dec 2025); $421K since January 2024 (5 contracts · 1 agency); 184th rank in the line (of 514 suppliers · 0.0%); 11 agencies never served ($9.3B on the line without UROGEN PHARMA INC).

Assay record ASY-US-1OTYAUR1EE · Cite as: Assay Systems, “UROGEN PHARMA INC: 5 government contracts in the United States since 2024”, https://assay-systems.com/register/us/urogen-pharma-inc/

8
contracts, all years
$811,169 · Jun 2023 – Dec 2025
$421K
since January 2024
5 contracts · 1 agency
184th
rank in the line
of 514 suppliers · 0.0%
11
agencies never served
$9.3B on the line without UROGEN PHARMA INC

Own record by year

2023 onward
$390K
$98.9K
$323K
202320242025

Who buys from UROGEN PHARMA INC

since January 2024
1agencies
$421Kpaid
100.0%top buyer
Department of Veterans Affairs100.0%
$421,449

Won without a rival

2024-03-21 – 2025-12-09
5uncontested awards
100%of its awards
0without a competition
5single bid

UROGEN PHARMA INC won 5 of its 5 public contract awards in United States without a rival from 2024-03-21 to 2025-12-09, worth $421K: 0 without a competition and 5 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Department of Veterans Affairs with 5.

Buyers: Department of Veterans Affairs (5)

Every uncontested award of UROGEN PHARMA INC · United States: all uncontested awards

The line

since January 2024
$28.2Bline value
158,923contracts
12agencies
514suppliers
96.4%held by top ten

Drugs and biologicals (6505)

$15.1B
$13.2B
20242025Jan–Nov
184thof 514 suppliers
$388,604UROGEN PHARMA INC in the line
0.0%share of the line
0.0%of $18,871,511,399 spent by Department of Veterans Affairs

Agencies that buy the line and never bought from UROGEN PHARMA INC

11agencies
156,670contracts
$9,335,952,323since January 2024
Department of Defense151,816 contracts
$7,145,190,573
Department of Health and Human Services985 contracts
$1,770,840,157
Department of Justice3,446 contracts
$367,934,841
Department of Agriculture21 contracts
$40,416,864
Department of State233 contracts
$8,285,468
Peace Corps158 contracts
$2,977,299
Department of Homeland Security5 contracts
$127,122
Department of the Interior2 contracts
$89,569
Department of the Treasury2 contracts
$50,300
Environmental Protection Agency1 contract
$27,529
Court Services and Offender Supervision Agency1 contract
$12,600

How the line is bought

by value, since 2024
2%no competition
1%one applicant
0of these to UROGEN PHARMA INC
Competed, several suppliers applied155,550 contracts
$27,184,127,568 · 96.4%
Awarded directly, no competition1,494 contracts
$630,079,768 · 2.2%
Competed, one supplier applied1,879 contracts
$393,256,385 · 1.4%

Contracts reaching their end dates

Oct 2026 – October 2027
81contracts
$633,969,668end by October 2027
22end in August 2027 · $39.5M
41in agencies never served · $606M
$10.8M
$3.8M
$4.5M
$34.2M
$2.8M
$1.4M
$38.9M
$447M
$1.2M
$39.5M
$49.6M
Oct 2618 contractsNov 269 contractsDec 265 contractsFeb 274 contractsMar 277 contractsApr 273 contractsMay 275 contractsJun 274 contractsJul 272 contractsAug 2722 contractsSep 272 contracts

Suppliers next to it in the line

since January 2024
VANTIVE US HEALTHCARE LLC2 contracts · 1 agency
$391,241
UROGEN PHARMA INC
$388,604
APL SALES I LLC15 contracts · 1 agency
$388,241
NEW ENGLAND BIOLABS, INC.13 contracts · 1 agency
$381,836

All 514 suppliers in the line

Fastest-growing supplier in the line

same line
+97%growth

Supplier UEI KABZK8W6PQT3

2024 to Nov 2025
$7,051,163,185
2022–2023
$3,579,627,887

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.